Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

United States, California

Adverum Clinical Site

Beverly Hills, California, United States, 90211

United States, Nevada

Adverum Clinical Site

Reno, Nevada, United States, 89502

United States, Pennsylvania

Adverum Clinical Site

Philadelphia, Pennsylvania, United States, 19107

United States, Texas

Adverum Clinical Site

Austin, Texas, United States, 78705

Adverum Clinical Site

Bellaire, Texas, United States, 77030

Adverum Clinical Site

The Woodlands, Texas, United States, 77384

Puerto Rico

Adverum Clinical Site

Arecibo, Puerto Rico, 00612

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 8, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments